Medical News

RSS

BioSpecifics Technologies total revenues for first-quarter increase to $2.7M

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the first quarter ended March 31, 2010. The Company also highlighted key commercial and regulatory progress during the quarter, and provided its expected milestones for the remainder of 2010.

7 May 2010

Warner Chilcott reports 209.5% increase in first-quarter 2010 revenues

Warner Chilcott plc today announced its results for the quarter ended March 31, 2010. Revenue in the quarter was $761.3 million, an increase of $515.3 million, or 209.5%, over the prior year quarter.

7 May 2010

First Edition: May 7, 2010

Today's health policy headlines explore a range of issues -- from how health reform politics are playing in midterm election campaigns to hospital action in the marketplace.

7 May 2010

Manual provides laboratory methods, information and resources on new collection of model species

Mice, frogs, and E. coli are standard organisms in biology laboratories. But in the last few years, due in part to technical advances, the reduced costs of genome sequencing, and increased interest in evolution and development, the range of organisms used for research has greatly expanded. Scientists now have more flexibility in choosing a model system that might better address their specific research question.

7 May 2010

Closer to understanding age-related memory loss and drug to boost memory

The world's scientific community may be one step closer to understanding age-related memory loss, and to developing a drug that might help boost memory. In an editorial published May 7 in Science, J. David Sweatt, Ph.D., chair of the University of Alabama at Birmingham (UAB) Department of Neurobiology, says that drugs known as histone deacetylase inhibitors are showing great promise in stopping memory loss - and even in boosting the formation of memory in animal models.

7 May 2010

MUHC's Henry C. Witelson Ocular Pathology Laboratory celebrates tenth anniversary

The Burnier International Ocular Pathology Society is holding a Scientific Colloquium in Montreal today to mark the tenth anniversary of the McGill University Health Centre's Henry C. Witelson Ocular Pathology Laboratory. The lab is an internationally reputed centre for the study and treatment of eye diseases and is leading a global network for the sharing of healthcare knowledge and expertise.

7 May 2010

New changes to 'Extra Help' program enables more people save on prescription drug costs

Medicare beneficiaries who qualify for "Extra Help" may be eligible to pay no more than $2.50 for generic drugs and $6.30 for each brand name drug thanks to changes to Medicare's Low-Income Subsidy Program for Part D prescription drug costs (also known as LIS or "Extra Help") that take effect this year. These changes make it easier than ever for people on Medicare with limited incomes to save on their drug costs.

7 May 2010

Researchers investigate effects of fatigue on neurosurgery resident performance

There are more than 6,000 U.S. hospitals, with approximately 3,500 actively practicing board-certified neurosurgeons serving a population of over 303 million people. About 150 neurosurgery residents graduate every year from the 99 accredited U.S. neurosurgery training programs.

7 May 2010

Socioeconomic status, social context more important than race when analyzing obesity disparities: Study

When analyzing obesity disparities among women, socioeconomic status and social context may be more important than race, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health's Hopkins Center for Health Disparities Solutions.

7 May 2010

DNA capture techniques enable sequencing of ancient Neandertal DNA

Researchers from the Max Planck Institute (MPI), Cold Spring Harbor Laboratory (CSHL), Agilent Technologies Inc., and other prestigious institutions worldwide have shown that DNA capture techniques can greatly enable the sequencing of ancient Neandertal DNA, providing new insight into the nature of these prehistoric hominids.

7 May 2010

Over 22% of non-elderly Americans may be denied coverage due to pre-existing health conditions

Approximately 57.2 million people under the age of 65—more than one in five (22.4 percent) of America's non-elderly population—have a diagnosed pre-existing condition that could lead to a denial of coverage in the individual health insurance market, according to a report released today by the consumer health organization Families USA.

7 May 2010

First 25 recipients of Frank Lanza Memorial Scholarship Program announced

The American Association of Community Colleges (AACC) and Phi Theta Kappa Honor Society, with the generous support of METI and L-3 Communications, Inc., have announced the first 25 recipients of the Frank Lanza Memorial Scholarship Program. The scholarships recognize the accomplishments of students enrolled in allied health programs offered by regionally accredited community colleges. Twenty-five students received scholarships of $1,000 each.

7 May 2010

Investment report on Keryx Biopharmaceutical from MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Keryx Biopharmaceutical Inc. The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.

7 May 2010

M-3 Information introduces iPhone application for depression, anxiety disorders

M-3 Information entered the smart phone application environment by offering the M-3 Checklist, a scientifically validated screen for depression and anxiety disorders, at the iTunes store on Friday, April 30, 2010. Adapted from M-3 Information's existing mymoodmonitor.com website, this mobile version, called mym3, provides the same validated mental health questionnaire optimized for smart phones. A first in iPhone applications, mym3 is designed to create a bridge between user responses and recommendations set forth in the content-rich M3 website application.

7 May 2010

Town hall meeting to address negative health, societal consequences of methamphetamine abuse

Pan American Bank (Los Angeles) today announced that it has partnered with the UCLA Youth Methamphetamine Treatment Study, LatinoGraduate.net and The Wall-Las Memorias Project to host a town hall meeting that addresses the negative health and societal consequences of methamphetamine abuse by Latino youth.

7 May 2010

MicroStockProfit.com releases NexMed investment report

MicroStockProfit.com announces an investment report featuring NexMed Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

7 May 2010

First clinical trial results of camera chip implanted under retina presented at 2010 ARVO meeting

Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings from their first clinical trial in which blind patients were able to view and focus on objects as their eye and head naturally moved as opposed to needing to constantly move their head to scan a scene, which is the case for other implants in which a camera is mounted to the patient's head.

7 May 2010

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.

7 May 2010

HTRN's revenue for fourth-quarter 2009 totaled $50.3M: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring HealthTronics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

7 May 2010

Aceto third-quarter net sales up 24.5% to $99.3 million

Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced results of operations for its fiscal 2010 third quarter and nine months ended March 31, 2010.

7 May 2010

Medical News

BioSpecifics Technologies total revenues for first-quarter increase to $2.7M

Warner Chilcott reports 209.5% increase in first-quarter 2010 revenues

First Edition: May 7, 2010

Manual provides laboratory methods, information and resources on new collection of model species

Closer to understanding age-related memory loss and drug to boost memory

MUHC's Henry C. Witelson Ocular Pathology Laboratory celebrates tenth anniversary

New changes to 'Extra Help' program enables more people save on prescription drug costs

Researchers investigate effects of fatigue on neurosurgery resident performance

Socioeconomic status, social context more important than race when analyzing obesity disparities: Study

DNA capture techniques enable sequencing of ancient Neandertal DNA

Over 22% of non-elderly Americans may be denied coverage due to pre-existing health conditions

First 25 recipients of Frank Lanza Memorial Scholarship Program announced

Investment report on Keryx Biopharmaceutical from MicroStockProfit.com

M-3 Information introduces iPhone application for depression, anxiety disorders

Town hall meeting to address negative health, societal consequences of methamphetamine abuse

MicroStockProfit.com releases NexMed investment report

First clinical trial results of camera chip implanted under retina presented at 2010 ARVO meeting

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

HTRN's revenue for fourth-quarter 2009 totaled $50.3M: MicroStockProfit.com

Aceto third-quarter net sales up 24.5% to $99.3 million

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News